|
|
| | TAK-931 Basic information |
| Product Name: | TAK-931 | | Synonyms: | 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1~{H}-pyrazol-4-yl)-3~{H}-thieno[3,2-d]pyrimidin-4-one;SIMUROSERTIB;TAK-931;(S)-6-(3-methyl-1H-pyrazol-4-yl)-2-(quinuclidin-2-yl)thieno[3,2-d]pyrimidin-4(3H)-one;Simurosertib (TAK-931);Thieno[3,2-d]pyrimidin-4(3H)-one, 2-(2S)-1-azabicyclo[2.2.2]oct-2-yl-6-(3-methyl-1H-pyrazol-4-yl)-;TAK-931，Simurosertib;Inhibitor,anti-cancer,Cyclin dependent kinase,ATP-competitive,CDK,TAK931,Simurosertib,cycle,cell,orally,inhibit,division,TAK 931 | | CAS: | 1330782-76-7 | | MF: | C17H19N5OS | | MW: | 341.43 | | EINECS: | | | Product Categories: | | | Mol File: | 1330782-76-7.mol |  |
| | TAK-931 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO: soluble | | form | A solid |
| | TAK-931 Usage And Synthesis |
| | TAK-931 Preparation Products And Raw materials |
|